Takeda Pharmaceutical Company Limited Stock Forecast
Takeda Pharmaceutical Company Limited stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session.
(Updated on Jun 25, 2024)
The Takeda Pharmaceutical Company Limited stock price gained 1.98% on the last trading day (Tuesday, 25th Jun 2024), rising from JP¥4,095.00 to JP¥4,176.00. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.43% from a day low at JP¥4,129.00 to a day high of JP¥4,188.00. The price has risen in 5 of the last 10 days but is still down by -1.02% for this period. Volume fell on the last day by -41 thousand shares and in total, 4 million shares were bought and sold for approximately JP¥16.48 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Takeda Pharmaceutical Company Limited stock with a 90% probability to be traded between JP¥3,981.81 and JP¥4,193.14 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
4502.T Signals & Forecast
The Takeda Pharmaceutical Company Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at JP¥4,079.43 and JP¥4,137.80. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 19, 2024, and so far it has risen 3.80%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Takeda Pharmaceutical Company Limited stock
Takeda Pharmaceutical Company Limited finds support from accumulated volume at JP¥4,173.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved JP¥59.00 between high and low, or 1.43%. For the last week the stock has had daily average volatility of 1.33%.
Our recommended stop-loss: JP¥3,971.57 (-4.90%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 11 days ago.)
Trading Expectations (4502.T) For The Upcoming Trading Day Of Wednesday 26th
For the upcoming trading day on Wednesday, 26th we expect Takeda Pharmaceutical Company Limited to open at JP¥4,164.33, and during the day (based on 14 day Average True Range), to move between JP¥4,116.01 and JP¥4,235.99, which gives a possible trading interval of +/-JP¥59.99 (+/-1.44%) up or down from last closing price. If Takeda Pharmaceutical Company Limited takes out the full calculated possible swing range there will be an estimated 2.87% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at JP¥4,173.00 (0.07%) than the resistance at JP¥4,184.00 (0.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Takeda Pharmaceutical Company Limited stock A Buy?
Takeda Pharmaceutical Company Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.618 Hold/Accumulate Upgraded
Predicted Opening Price for Takeda Pharmaceutical Company Limited of Wednesday, June 26, 2024
Fair opening price June 26, 2024 | Current price |
---|---|
JP¥4,164.33 ( 0.279%) | JP¥4,176.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 4502.T
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 4,223.33 | 1.13% |
R2 | 4,200.80 | 0.594% |
R1 | 4,186.87 | 0.260% |
Price | 4,176.00 | |
S1 | 4,141.80 | -0.82% |
S2 | 4,127.87 | -1.15% |
S3 | 4,105.33 | -1.69% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 4,388.00 | 5.08% |
R2 | 4,203.00 | 0.647% |
R1 | 4,184.00 | 0.192% |
Price | 4,176.00 | |
S1 | 4,173.00 | -0.0718% |
S2 | 4,129.00 | -1.13% |
S3 | 4,102.00 | -1.77% |
4502 Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Sep 27, 2024 | Sep 27, 2024 | Sep 27, 2024 | JP¥0 | 0% |
2 | Mar 28, 2024 | Mar 28, 2024 | Jun 27, 2024 | JP¥94.00 | 2.25% |
3 | Sep 28, 2023 | Sep 28, 2023 | Dec 01, 2023 | JP¥94.00 | 2.25% |
4 | Mar 30, 2023 | Mar 30, 2023 | Mar 30, 2023 | JP¥90.00 | 2.08% |
5 | Sep 29, 2022 | Sep 29, 2022 | Sep 29, 2022 | JP¥90.00 | 2.38% |
FAQ
Click here for our free guide on how to buy Takeda Pharmaceutical Company Limited Stock.